The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 7, 2005, Pages 1206-1213

  Campos, Joaquin ^a   Gonzalez Quintela, Arturo ^a   Quinteiro, Celsa ^b   Gude, Francisco ^a   Perez, Luis Fernando ^a   Torre, Jose Antonio ^a   Vidal, Carmen ^a  

^a Instituto de Salud Carlos III   (Spain)

^b Unidad de Medicina Molecular   (Spain)

Author keywords

Acute phase proteins; Alcohol; CD14; Cirrhosis; Genes; Immunoglobulins; Polymorphisms

Indexed keywords

ACUTE PHASE PROTEIN; ALCOHOL; C REACTIVE PROTEIN; CD14 ANTIGEN; ENDOTOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; ASCITES; CD14 GENE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEPATIC ENCEPHALOPATHY; HUMAN; INFLAMMATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE-PHASE PROTEINS; ADULT; AGED; ANTIGENS, CD14; C-REACTIVE PROTEIN; CARRIER PROTEINS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; IMMUNOGLOBULINS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; SPAIN;

EID: 23044497409     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000171977.25531.7A     Document Type: Article

References (44)

1. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, Ruiz del Arbol L, Alvarez-Mon M (2003) Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37:208-217.
2. Andreotti F, Porto I, Crea F, Maseri A (2002) Inflammatory gene polymorphisms and ischaemic heart disease: a review of population association studies. Heart 87:107-112.
3. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD (1999) A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20:976-983.
4. Barrio E, Tome S, Rodriguez I, Gude F, Sanchez-Leira J, Perez Becerra E, Gonzalez-Quintela A (2004) Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol Clin Exp Res 28:131-136.
5. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute-phase protein. J Immunol 172:4470-4479.
6. Bautista AP (2000) Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 15:349-356.
7. Bazil V, Strominger JL (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567-1574.
8. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23:1025-1029.
9. Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279:48487-48490.
10. Bode C, Kugler V, Bode JC (1987) Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4:8-14.
11. Enomoto N, Takase S, Takada N, Takada A (1991) Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. Hepatology 13:1071-1075.
12. Frank J, Witte K, Schrodl W, Schutt C (2004) Chronic alcoholism causes deleterious conditioning of innate immunity. Alcohol Alcohol 39:386-392.
13. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176:1665-1671.
14. Grove J, Daly AK, Bassendine MF, Day CP (1997) Association of tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26:143-146.
15. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP (2000) Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 46:540-545.
16. Gual A, Martos AR, Lligona A, Llopis JJ (1999) Does the concept of a standard drink apply to viticultural societies? Alcohol Alcohol 34:153-160.
17. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM (1994) Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J Immunol 152:5868-5876.
18. Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhurien PJ, Lindros KO (2001) Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33:1148-1153.
19. Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannen PJ, Giroir BP (2000) Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 117:1706-1712.
20. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167:5838-5844.
21. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182.
22. Lukkari TA, Jarvelainen HA, Oinonen T, Kettunen E, Lindros KO (1999) Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol Alcohol 34:311-319.
23. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S (2002) Monocyte activation in alcoholic liver disease. Alcohol 27:53-61.
24. Moshage H (1997) Cytokines and the hepatic acute phase response. J Pathol 181:257-266.
25. Nagy LE (2003) Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 228:882-890.
26. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108-111.
27. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R, Rodes J (1990) Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 12:1295-1299.
28. Poullis AP, Shetty AK, Risley PD, Collinson PO, Mendall MA (2003) Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity. Eur J Gastroenterol Hepatol 15:1317-1322.
29. Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ (1993) Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 17:1112-1117.
30. Schafer C, Parlesak A, Schutt C, Bode CJ, Bode C (2002) Concentrations of lipopolysaccharide binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxemia in patients with alcoholic liver disease. Alcohol Alcohol 37:81-86.
31. Schumann RR, Latz E (2000) Lipopolysaccharide-binding protein. Chem Immunol 74:42-60.
32. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
33. Schumann RR, Zweigner J (1999) A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37:271-274.
34. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C (1992) Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 143:71-78.
35. Szabo G (1999) Consequences of alcohol consumption on host defence. Alcohol Alcohol 34:830-841.
36. Tiret L (2002) Gene-environment interaction: a central concept in multifactorial diseases. Proc Nutr Soc 61:457-463.
37. Triantafilou M, Triantafilou K (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23:301-304.
38. Tsutsumi M, Takada A, Wang JS (1994) Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 107:1430-1435.
39. Ulevitch RJ, Tobias PS (1999) Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 11:19-22.
40. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W (1999) A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic profile. Arterioscler Thromb Vasc Biol 19:932-938.
41. Van de Wiel A, Van Hattum J, Schuurman HJ, Kater L (1988) Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 94:457-462.
42. Vercelli D (2002) The functional genomics of CD14 and its role in IgE responses: an integrated view. J Allergy Clin Immunol 109:14-21.
43. Yamauchi M, Maezawa Y, Toda G, Suzuki H, Sakurai S (1995) Association of a restriction fragment length polymorphism in the alcohol dehydrogenase 2 gene with Japanese alcoholic liver cirrhosis. J Hepatol 23:519-523.
44. Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, Goyert SM, Thurman RG (2001) Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 166:4737-4742.